Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Impact of coronary heart disease on cognitive decline in Alzheimer's disease: a prospective longitudinal cohort study in primary care.

Bleckwenn M, Kleineidam L, Wagner M, Jessen F, Weyerer S, Werle J, Wiese B, Lühmann D, Posselt T, König HH, Brettschneider C, Mösch E, Weeg D, Fuchs A, Pentzek M, Luck T, Riedel-Heller SG, Maier W, Scherer M.

Br J Gen Pract. 2017 Feb;67(655):e111-e117. doi: 10.3399/bjgp16X688813. Epub 2016 Dec 19.

2.

Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery.

Kim J, Na HK, Byun J, Shin J, Kim S, Lee BH, Na DL.

Dement Geriatr Cogn Disord. 2017;44(1-2):105-117. doi: 10.1159/000478520. Epub 2017 Aug 3.

PMID:
28768247
3.

Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.

Bergland AK, Dalen I, Larsen AI, Aarsland D, Soennesyn H.

J Alzheimers Dis. 2017;56(2):575-584. doi: 10.3233/JAD-160847.

PMID:
28035932
4.

Effects of APOE haplotypes and measures of cardiovascular risk over gender-dependent cognitive and functional changes in one year in Alzheimer's disease.

de Oliveira FF, Pereira FV, Pivi GAK, Smith MC, Bertolucci PHF.

Int J Neurosci. 2018 May;128(5):472-476. doi: 10.1080/00207454.2017.1396986. Epub 2017 Nov 21.

PMID:
29064737
5.

Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I.

J Am Geriatr Soc. 2015 Sep;63(9):1749-56. doi: 10.1111/jgs.13627.

6.

Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.

Monsell SE, Liu D, Weintraub S, Kukull WA.

Int Psychogeriatr. 2012 Oct;24(10):1553-60. doi: 10.1017/S1041610212000452. Epub 2012 Apr 16.

7.

Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.

Besser LM, Litvan I, Monsell SE, Mock C, Weintraub S, Zhou XH, Kukull W.

Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.

8.

Vascular factors predict rate of progression in Alzheimer disease.

Mielke MM, Rosenberg PB, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG.

Neurology. 2007 Nov 6;69(19):1850-8.

PMID:
17984453
9.

The correlation between cerebral arterial pulsatility and cognitive dysfunction in Alzheimer's disease patients.

Lim JS, Lee JY, Kwon HM, Lee YS.

J Neurol Sci. 2017 Feb 15;373:285-288. doi: 10.1016/j.jns.2017.01.001. Epub 2017 Jan 4.

PMID:
28131207
10.

Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer's Disease Cooperative Study Cognitive Function Instrument.

Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, Karantzoulis S, Aisen PS, Sperling RA; Alzheimer’s Disease Cooperative Study.

JAMA Neurol. 2015 Apr;72(4):446-54. doi: 10.1001/jamaneurol.2014.3375. Erratum in: JAMA Neurol. 2015 May;72(5):608.

11.

Faster cognitive and functional decline in Dysexecutive versus amnestic Alzheimer's subgroups: a longitudinal analysis of the National Alzheimer's Coordinating Center (NACC) database.

Mez J, Cosentino S, Brickman AM, Huey ED, Manly JJ, Mayeux R.

PLoS One. 2013 Jun 3;8(6):e65246. doi: 10.1371/journal.pone.0065246. Print 2013.

12.

Effects of education on the progression of early- versus late-stage mild cognitive impairment.

Ye BS, Seo SW, Cho H, Kim SY, Lee JS, Kim EJ, Lee Y, Back JH, Hong CH, Choi SH, Park KW, Ku BD, Moon SY, Kim S, Han SH, Lee JH, Cheong HK, Na DL.

Int Psychogeriatr. 2013 Apr;25(4):597-606. doi: 10.1017/S1041610212002001. Epub 2012 Dec 4.

PMID:
23207181
13.

Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.

Steenland K, Zhao L, Goldstein FC, Levey AI.

J Am Geriatr Soc. 2013 Sep;61(9):1449-55. doi: 10.1111/jgs.12414. Epub 2013 Sep 3.

14.

Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.

Mangialasche F, Solomon A, Kåreholt I, Hooshmand B, Cecchetti R, Fratiglioni L, Soininen H, Laatikainen T, Mecocci P, Kivipelto M.

Exp Gerontol. 2013 Dec;48(12):1428-35. doi: 10.1016/j.exger.2013.09.006. Epub 2013 Oct 7.

PMID:
24113154
15.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

PMID:
25740785
16.

Frailty Index and Cognitive Decline in Alzheimer's Disease: Data from the Impact of Cholinergic Treatment USe Study.

Kelaiditi E, Canevelli M, Andrieu S, Del Campo N, Soto ME, Vellas B, Cesari M; Impact of Cholinergic Treatment Use Study/DSA Group.

J Am Geriatr Soc. 2016 Jun;64(6):1165-70. doi: 10.1111/jgs.13956.

PMID:
27321595
17.

Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.

Musicco M, Palmer K, Salamone G, Lupo F, Perri R, Mosti S, Spalletta G, di Iulio F, Pettenati C, Cravello L, Caltagirone C.

J Neurol. 2009 Aug;256(8):1288-95. doi: 10.1007/s00415-009-5116-4. Epub 2009 Apr 8.

18.

Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.

Handels RL, Xu W, Rizzuto D, Caracciolo B, Wang R, Winblad B, Verhey FR, Severens JL, Fratiglioni L, Joore MA, Wimo A.

J Alzheimers Dis. 2013;37(2):357-65. doi: 10.3233/JAD-130296.

PMID:
23948894
19.

Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.

Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA; AIBL Research Group.

Int Psychogeriatr. 2012 Feb;24(2):197-204. doi: 10.1017/S1041610211001335. Epub 2011 Jul 13.

PMID:
21749739
20.

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Portelius E, Zetterberg H, Skillbäck T, Törnqvist U, Andreasson U, Trojanowski JQ, Weiner MW, Shaw LM, Mattsson N, Blennow K; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Nov;138(Pt 11):3373-85. doi: 10.1093/brain/awv267. Epub 2015 Sep 15.

Supplemental Content

Support Center